BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

608 related articles for article (PubMed ID: 29907693)

  • 1. Exosomes Shuttle TREX1-Sensitive IFN-Stimulatory dsDNA from Irradiated Cancer Cells to DCs.
    Diamond JM; Vanpouille-Box C; Spada S; Rudqvist NP; Chapman JR; Ueberheide BM; Pilones KA; Sarfraz Y; Formenti SC; Demaria S
    Cancer Immunol Res; 2018 Aug; 6(8):910-920. PubMed ID: 29907693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity.
    Vanpouille-Box C; Alard A; Aryankalayil MJ; Sarfraz Y; Diamond JM; Schneider RJ; Inghirami G; Coleman CN; Formenti SC; Demaria S
    Nat Commun; 2017 Jun; 8():15618. PubMed ID: 28598415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dendritic cell-derived exosomes elicit tumor regression in autochthonous hepatocellular carcinoma mouse models.
    Lu Z; Zuo B; Jing R; Gao X; Rao Q; Liu Z; Qi H; Guo H; Yin H
    J Hepatol; 2017 Oct; 67(4):739-748. PubMed ID: 28549917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic profile of dendritic and T cells in the lymph node of Balb/C mice with breast cancer submitted to dendritic cells immunotherapy.
    da Cunha A; Antoniazi Michelin M; Cândido Murta EF
    Immunol Lett; 2016 Sep; 177():25-37. PubMed ID: 27423825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Manganese is critical for antitumor immune responses via cGAS-STING and improves the efficacy of clinical immunotherapy.
    Lv M; Chen M; Zhang R; Zhang W; Wang C; Zhang Y; Wei X; Guan Y; Liu J; Feng K; Jing M; Wang X; Liu YC; Mei Q; Han W; Jiang Z
    Cell Res; 2020 Nov; 30(11):966-979. PubMed ID: 32839553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adding liposomal doxorubicin enhances the abscopal effect induced by radiation/αPD1 therapy depending on tumor cell mitochondrial DNA and cGAS/STING.
    Wang L; Luo R; Onyshchenko K; Rao X; Wang M; Menz B; Gaedicke S; Grosu AL; Firat E; Niedermann G
    J Immunother Cancer; 2023 Aug; 11(8):. PubMed ID: 37640480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TREX1 as a Novel Immunotherapeutic Target.
    Hemphill WO; Simpson SR; Liu M; Salsbury FR; Hollis T; Grayson JM; Perrino FW
    Front Immunol; 2021; 12():660184. PubMed ID: 33868310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual effect of DLBCL-derived EXOs in lymphoma to improve DC vaccine efficacy in vitro while favor tumorgenesis in vivo.
    Chen Z; You L; Wang L; Huang X; Liu H; Wei JY; Zhu L; Qian W
    J Exp Clin Cancer Res; 2018 Aug; 37(1):190. PubMed ID: 30103789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA-Containing Exosomes Derived from Cancer Cells Treated with Topotecan Activate a STING-Dependent Pathway and Reinforce Antitumor Immunity.
    Kitai Y; Kawasaki T; Sueyoshi T; Kobiyama K; Ishii KJ; Zou J; Akira S; Matsuda T; Kawai T
    J Immunol; 2017 Feb; 198(4):1649-1659. PubMed ID: 28069806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type I interferon activates MHC class I-dressed CD11b
    Duong E; Fessenden TB; Lutz E; Dinter T; Yim L; Blatt S; Bhutkar A; Wittrup KD; Spranger S
    Immunity; 2022 Feb; 55(2):308-323.e9. PubMed ID: 34800368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting DNA damage response components induces enhanced STING-dependent type-I IFN response in ATM deficient cancer cells and drives dendritic cell activation.
    Lopez-Pelaez M; Young L; Vazquez-Chantada M; Nelson N; Durant S; Wilkinson RW; Poon E; Gaspar M; Valge-Archer V; Smith P; Dovedi SJ
    Oncoimmunology; 2022; 11(1):2117321. PubMed ID: 36117525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased numbers of monocyte-derived dendritic cells during successful tumor immunotherapy with immune-activating agents.
    Kuhn S; Hyde EJ; Yang J; Rich FJ; Harper JL; Kirman JR; Ronchese F
    J Immunol; 2013 Aug; 191(4):1984-92. PubMed ID: 23858033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-free tumor microparticle vaccines stimulate dendritic cells via cGAS/STING signaling.
    Zhang H; Tang K; Zhang Y; Ma R; Ma J; Li Y; Luo S; Liang X; Ji T; Gu Z; Lu J; He W; Cao X; Wan Y; Huang B
    Cancer Immunol Res; 2015 Feb; 3(2):196-205. PubMed ID: 25477253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutting Edge: cGAS Is Required for Lethal Autoimmune Disease in the Trex1-Deficient Mouse Model of Aicardi-Goutières Syndrome.
    Gray EE; Treuting PM; Woodward JJ; Stetson DB
    J Immunol; 2015 Sep; 195(5):1939-43. PubMed ID: 26223655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell-based cancer vaccination.
    Galea-Lauri J; Wells JW; Darling D; Harrison P; Farzaneh F
    Cancer Immunol Immunother; 2004 Nov; 53(11):963-77. PubMed ID: 15146294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-15 is expressed by dendritic cells in response to type I IFN, double-stranded RNA, or lipopolysaccharide and promotes dendritic cell activation.
    Mattei F; Schiavoni G; Belardelli F; Tough DF
    J Immunol; 2001 Aug; 167(3):1179-87. PubMed ID: 11466332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor cell-derived exosome-targeted dendritic cells stimulate stronger CD8+ CTL responses and antitumor immunities.
    Yao Y; Chen L; Wei W; Deng X; Ma L; Hao S
    Biochem Biophys Res Commun; 2013 Jun; 436(1):60-5. PubMed ID: 23707941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD40-independent natural killer-cell help promotes dendritic cell vaccine-induced T-cell immunity against endogenous B-cell lymphoma.
    Hömberg N; Adam C; Riedel T; Brenner C; Flatley A; Röcken M; Mocikat R
    Int J Cancer; 2014 Dec; 135(12):2825-33. PubMed ID: 24771135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved vaccine efficacy of tumor exosome compared to tumor lysate loaded dendritic cells in mice.
    Gu X; Erb U; Büchler MW; Zöller M
    Int J Cancer; 2015 Feb; 136(4):E74-84. PubMed ID: 25066479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. STING activation of tumor endothelial cells initiates spontaneous and therapeutic antitumor immunity.
    Demaria O; De Gassart A; Coso S; Gestermann N; Di Domizio J; Flatz L; Gaide O; Michielin O; Hwu P; Petrova TV; Martinon F; Modlin RL; Speiser DE; Gilliet M
    Proc Natl Acad Sci U S A; 2015 Dec; 112(50):15408-13. PubMed ID: 26607445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.